Abatacept s.c. for aGVHD Prevention in Haplo-HCT
NCT04686929
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
29
Enrollment
OTHER
Sponsor class
Conditions
Abatacept
Acute-graft-versus-host Disease
Haplo-identical HCT
Prevention
Interventions
DRUG:
Abatacept s.c.
Sponsor
The First Affiliated Hospital of Soochow University